Dr. Robert Paul Zusman is a Port Charlotte, Florida based physiatrist who is specialized in Pain Management (PM&R). Active license number of Dr. Robert Paul Zusman as Pain Management (PM&R) is OS20712 in Florida.
Dr. Robert Paul Zusman provides a high level of care, either as a primary physician or consultant, for patients experiencing problems with acute, chronic or cancer pain in both hospital and ambulatory settings. Patient care needs may also be coordinated with other specialists.
Complete Profile:
Dr. Robert Paul Zusman speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Pain Management (PM&R)
Credentials:
DO
Gender:
Male
Practice Address:
1641 Tamiami Trl Ste 1, Port Charlotte, Florida, 33948-1018
Phone:
941-629-6262
Fax:
941-629-1782
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1053870899
NPI Enumeration Date:
19 Mar, 2019
NPI Last Update On:
04 Sep, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Robert Paul Zusman are as mentioned below.
License Number
Specialization
State
Status
OS20712
Pain Management
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6500 38th Ave N, St Petersburg, Florida
Zip:
33710-1629
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Robert Paul Zusman at 1641 Tamiami Trl Ste 1, Port Charlotte, Florida or can call to book an appointment on 941-629-6262. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.